Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.334 SEK | +9.88% | -1.91% | -23.11% |
05-08 | Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-14 | Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 28
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small Molecules Drug
100.0
%
| 0 | 100.0 % | 50 | 100.0 % | +60,725.30% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
99.9
%
| 0 | 42.2 % | 50 | 99.9 % | +144,028.57% |
Sweden
0.1
%
| 0 | 57.8 % | 0 | 0.1 % | -14.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Johan Emilsson
CEO | Chief Executive Officer | 40 | 23-09-30 |
Martin Andersson
FOU | Founder | 53 | 08-12-31 |
Director of Finance/CFO | 51 | 10-12-31 | |
Corporate Officer/Principal | - | 10-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 19-12-31 | |
Chairman | 56 | 20-12-31 | |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 18-12-31 |
Director/Board Member | 68 | 09-12-31 | |
Karin From
BRD | Director/Board Member | 54 | 22-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,820,090 | 32,956,722 ( 47.20 %) | 0 | 47.20 % |
Company contact information
Sprint Bioscience AB
Hälsovägen 7 8th Floor, elevator A
141 57, Huddinge
+46 84 11 44 55
http://www.sprintbioscience.comSector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.11% | 7.83M | |
+7.30% | 111B | |
+11.34% | 106B | |
-12.69% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.57% | 16.81B | |
+37.35% | 12.54B | |
-24.02% | 8.09B |
- Stock Market
- Equities
- SPRINT Stock
- Company Sprint Bioscience AB